EMPLOYMENT AGREEMENTEmployment Agreement • March 14th, 2022 • Solid Biosciences Inc. • Biological products, (no disgnostic substances) • Delaware
THIS EMPLOYMENT AGREEMENT (the “Agreement”), is made as of January 25, 2019 by and between Solid Biosciences Inc. (the “Company”), and Dr. Joel Schneider (the “Executive”) (together, the “Parties”).
Restricted Stock Unit AgreementRestricted Stock Unit Agreement • March 14th, 2022 • Solid Biosciences Inc. • Biological products, (no disgnostic substances)
This grant of RSUs satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
Employment Agreement with Erin BrennanEmployment Agreement • March 14th, 2022 • Solid Biosciences Inc. • Biological products, (no disgnostic substances)
Pursuant to her employment agreement, Ms. Brennan is being paid an annual base salary of $410,000 for 2021, which base salary will be reviewed by the board of directors from time to time and is subject to change in the discretion of the board of directors. Ms. Brennan is also eligible to earn an annual performance bonus, with a target bonus amount equal to up to 40% of her base salary, based upon the board’s assessment of her performance and the Company’s attainment of targeted goals as set by the board in its sole discretion. The bonus may be in the form of cash, equity award(s), or a combination of cash and equity.
Solid Biosciences Inc. Executive Chairman AgreementExecutive Chair Agreement • March 14th, 2022 • Solid Biosciences Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Executive Chair Agreement (together with Exhibit A, the “Agreement”), effective January 1, 2022 (the “Effective Date”), is by and between Ian F. Smith, an individual having an address at 45 Commonwealth Avenue, Unit 3, Boston, MA 02116 (the “Executive Chair”), and Solid Biosciences Inc., a Delaware corporation (together with its affiliates, the “Company”), having an address at 141 Portland Street, Fifth Floor, Cambridge, MA 02139.
FIRST AMENDMENT TO SUBLEASESolid Biosciences Inc. • March 14th, 2022 • Biological products, (no disgnostic substances)
THIS FIRST AMENDMENT TO SUBLEASE (“First Amendment”) is entered into as of December 3, 2021 (the “First Amendment Effective Date”), by and between TWITTER, INC., a Delaware corporation (“Sublandlord”), and SOLID BIOSCIENCES, LLC, a Delaware limited liability company (“Subtenant”), with reference to the following facts:
